Importation
Husband of Former Pennsylvania Township Commissioner Charged in Fake Online Pharmacy Case
Koledin ran a website called awakebrain dot com that marketed and sold misbranded and unapproved medication imported from Russia and China. It describes several instances when either the website or emails from Koledin described medications as FDA-approved, when in fact they were not.
[...]ALEC’s Health and Human Services Task Force Director: “Don’t Import Prescription Drugs”
In this editorial published in The Hill on May 12, 2019, Brooklyn Roberts, the director of the health and human services task force at the American Legislative Exchange Council, discusses the risks of drug importation:
“The safety of our prescription drugs relies on a closed system where drugs can be traced to manufacturers, distributors, pharmacies and patients. Opening that system to foreign drugs would allow the potential for dangerous and potentially deadly medicines to land in the hands of the American public.”
[...]Former FDA Commissioner Scott Gottlieb condemns importation proposals and points out Florida’s sordid history with wholesale counterfeit drugs
Today at the National Press Club former FDA Commissioner Scott Gottlieb addressed the issue of importation and specifically talked about the irony of Florida attempting to do it. Commissioner Gottlieb reminded us that the reason we have the pedigree system we’re implementing now (Track and Trace) is because criminal wholesalers in Florida in the early…
[...]Partnership for Safe Medicines’ Statement in Response to President Trump’s Comments on Foreign Drug Importation
Washington, D.C. (May 9, 2019) – Shabbir Safdar, Executive Director of the Partnership for Safe Medicines, released the following statement in response to President Trump’s comments on drug importation: “We have worked on this issue for more than 15 years and it is simply not possible to import medicines safely from a foreign country’s drug…
[...]Former FBI Director Warns About the Hidden Risks of Drug Importation
In this editorial published on April 30, 2019, former FBI Director Louis Freeh talks about the safety risks of drug importation: “There are hidden risks and costs associated with the scheme that have not been getting much attention which impact your health and Colorado law enforcement’s ability to keep us safe.”
[...]New Mexico Pharmacists Association Expresses Concern Over Allowing Drug Importation In Letter to Congress
The New Mexico Pharmacists Association recently sent their own letter to members of Congress expressing their concerns about allowing drug importation. PSM had the chance to speak with their executive director to learn more about the realities and misconceptions that people have about prescription drugs and drug importation…
[...]Economist questions the fundamentals of importation: “It flunks a basic policy analysis.”
In this editorial published on April 26, 2019, Douglas Holtz-Eakin, economist and President of American Action Forum, questions economic truths about drug importation:
“Drug reimportation has long been the fool’s gold of health policy, and the Florida bill is no different. It flunks a basic policy analysis. But most amazing, it is drafted to raise hope, but not actually help Floridians.”
[...]Journalist on drug importation: “There is a real risk.”
In this piece published in the Washington Free Beacon on April 25, 2019, staff writer Charles Fain Lehman explores issues around Florida’s drug importation proposal. “Critics,” he notes, “fear that the actual realities of regulatory oversight—especially in the hand of an as-yet-unnamed private vendor—will simply be too challenging to manage responsibly.”
[...]Utah pharmacist and state senator: Importation raises “serious concerns about drug safety”
In this piece, which was published in The Deseret News on April 24, 2019, pharmacist and Utah State Senate Majority Leader Evan Vickers raises serious concerns about importation as a strategy to lower drug prices:
“Anyone who truly understands how drugs are sold and distributed in the U.S. knows that there are very solid technical reasons that such importation is not viable. There are also serious concerns about drug safety, since the CHS cannot guarantee origin and purity on foreign-sourced drugs.”
[...]The Bottom Line? “Importation will make it difficult to ensure that Floridians are receiving real and safe medicine.”
In this piece, which was published on the ABC affiliate WJLA’s website on April 25, 2019, political analyst Boris Epshteyn explains that “this is a risky plan that will make it difficult to ensure that Floridians are receiving real and safe medicine.”
[...]